Pancreatic cancer initiates an immune system response
Drug Target Review,
Studying pancreatic ductal adenocarcinoma tumours, researchers discovered 25 antibodies that responded to antigens.
Studying pancreatic ductal adenocarcinoma tumours, researchers discovered 25 antibodies that responded to antigens.
Recent findings at Cold Spring Harbor Laboratory (CSHL) shine a new light on pancreatic cancer.
Recent findings at Cold Spring Harbor Laboratory (CSHL) shine a new light on pancreatic cancer.
Researchers have discovered antibodies that interact with pancreatic cancer cells and healthy cells.